New patent for Glaxosmithkline drug TRELEGY ELLIPTA

Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…

The post New patent for Glaxosmithkline drug TRELEGY ELLIPTA appeared first on Biotechblog.

Published on Thu, 15 Oct 2020 00:09:45 +0000 with keywords Apptigent PowerTools